Mesoporous silica nanoparticles for pulmonary drug delivery
A Garcia-Fernandez, F Sancenon… - Advanced Drug Delivery …, 2021 - Elsevier
Over the last years, respiratory diseases represent a clinical concern, being included among
the leading causes of death in the world due to the lack of effective lung therapies, mainly …
the leading causes of death in the world due to the lack of effective lung therapies, mainly …
Acute respiratory distress syndrome and COVID-19: A literature review
M Hussain, S Khurram Syed, M Fatima… - Journal of …, 2021 - Taylor & Francis
Acute respiratory distress syndrome (ARDS) is an overwhelming inflammatory disorder of
the lung due to direct and indirect insults to the lungs. ARDS is characterized by increased …
the lung due to direct and indirect insults to the lungs. ARDS is characterized by increased …
[HTML][HTML] Rosuvastatin for sepsis-associated acute respiratory distress syndrome
TN Heart - The New England journal of medicine, 2014 - ncbi.nlm.nih.gov
BACKGROUND In the acute respiratory distress syndrome (ARDS), inflammation in the
lungs and other organs can cause life-threatening organ failure. Inhibitors of 3-hydroxy-3 …
lungs and other organs can cause life-threatening organ failure. Inhibitors of 3-hydroxy-3 …
Surfactant therapy for acute lung injury and acute respiratory distress syndrome
K Raghavendran, D Willson… - Critical care …, 2011 - criticalcare.theclinics.com
The extensive pulmonary alveolar and capillary networks make the lungs highly susceptible
to cell and tissue injury from pathogens or toxic environmental agents present either in the …
to cell and tissue injury from pathogens or toxic environmental agents present either in the …
A unifying passivity framework for network flow control
Network flow control regulates the traffic between sources and links based on congestion,
and plays a critical role in ensuring satisfactory performance. In recent studies, global …
and plays a critical role in ensuring satisfactory performance. In recent studies, global …
Neuromuscular blocking agents in ARDS
AS Slutsky - New England Journal of Medicine, 2010 - Mass Medical Soc
In this issue of the Journal, Papazian and colleagues1 present intriguing results of their
study examining neuromuscular blockade in patients with severe, early acute respiratory …
study examining neuromuscular blockade in patients with severe, early acute respiratory …
Pharmacological treatments in ARDS; a state-of-the-art update
AJ Boyle, RM Sweeney, DF McAuley - BMC medicine, 2013 - Springer
Despite its high incidence and devastating outcomes, acute respiratory distress syndrome
(ARDS) has no specific treatment, with effective therapy currently limited to minimizing …
(ARDS) has no specific treatment, with effective therapy currently limited to minimizing …
The COVID-19 pandemic: a target for surfactant therapy?
Introduction The dramatic impact of COVID-19 on humans worldwide has initiated an
extraordinary search for effective treatment approaches. One of these is the administration of …
extraordinary search for effective treatment approaches. One of these is the administration of …
Recent progress and prospects for anti-cytokine therapy in preclinical and clinical acute lung injury
GP Fadanni, JB Calixto - Cytokine & Growth Factor Reviews, 2023 - Elsevier
Acute respiratory distress syndrome (ARDS) is a heterogeneous cause of respiratory failure
that has a rapid onset, a high mortality rate, and for which there is no effective …
that has a rapid onset, a high mortality rate, and for which there is no effective …
Therapeutic applications of stem cells and extracellular vesicles in emergency care: futuristic perspectives
Regenerative medicine (RM) is an interdisciplinary field that aims to repair, replace or
regenerate damaged or missing tissue or organs to function as close as possible to its …
regenerate damaged or missing tissue or organs to function as close as possible to its …